开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2216718, encodeId=37a82216e18e9, content=7.11投稿 awaiting ED 7.12 awaiting VEIC 7.24 awaiting Adm 是不是要拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068534123, createdName=pello11, createdTime=Wed Jul 24 23:03:56 CST 2024, time=2024-07-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2120848, encodeId=a0b9212084884, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肺癌;小分子抑制剂 经验分享：2023.03.16 投稿后状态变化记录： 2023.03.17: Awaiting ED Assignment； 2023.03.21 : Awaiting VEIC Assignment; 目前是这样，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Tue Mar 21 19:05:18 CST 2023, time=2023-03-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215407, encodeId=deee221540ea8, content=所以Awaiting VEIC Assignment中的VEIC到底是个什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fbd9383449, createdName=ms9000002097584198, createdTime=Wed Jul 17 14:12:46 CST 2024, time=2024-07-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211596, encodeId=7eb9221159672, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：还是听艰难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0e5680489, createdName=ms2000001467090742, createdTime=Tue Jun 25 16:28:02 CST 2024, time=2024-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204838, encodeId=63ab2204838c3, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：很慢啊，投稿到等审稿人认领一个月，然后等打分又一个月，速度真的是可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc119232111, createdName=ms3000002125368567, createdTime=Wed May 15 15:43:04 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2171584, encodeId=09f421e1584f0, content=请问这个杂志Instructions for authors的要求和给到的template模板要求不一致，应该按照哪一个来呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4f28656115, createdName=ms2000000932153408, createdTime=Tue Nov 28 23:04:31 CST 2023, time=2023-11-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1218505, encodeId=b8a012185056e, content=请问Output Styles下载的该杂志的参考文献格式和杂志要求的不一样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84202197639, createdName=120a90fem13(暂无昵称), createdTime=Tue May 10 17:30:26 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150883, encodeId=3e82215088322, content=这个杂志如何提交原始数据？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57035473318, createdName=淡忘Lrc, createdTime=Wed Aug 02 08:46:58 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1214240, encodeId=f5b3121424009, content=偏重的研究方向：细胞生物学 经验分享：一直显示awaiting ED assignment多久会有<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>下一步啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=21, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37c95472737, createdName=ms1000001579516810, createdTime=Mon Apr 25 22:15:47 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051482, encodeId=ec28105148229, content=请问各位有遇到过投稿一个多月了，一直是waiting reviewer assignment的状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/DF260C6FE6A83E05AA005306C7FA653C/100, createdBy=2c722184101, createdName=CasRx, createdTime=Wed Sep 15 14:06:19 CST 2021, time=2021-09-15, status=1, ipAttribution=)]

2024-07-24 pello11 来自北京

7.11投稿 awaiting ED 7.12 awaiting VEIC 7.24 awaiting Adm 是不是要拒了？

51 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216718, encodeId=37a82216e18e9, content=7.11投稿 awaiting ED 7.12 awaiting VEIC 7.24 awaiting Adm 是不是要拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068534123, createdName=pello11, createdTime=Wed Jul 24 23:03:56 CST 2024, time=2024-07-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2120848, encodeId=a0b9212084884, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肺癌;小分子抑制剂 经验分享：2023.03.16 投稿后状态变化记录： 2023.03.17: Awaiting ED Assignment； 2023.03.21 : Awaiting VEIC Assignment; 目前是这样，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Tue Mar 21 19:05:18 CST 2023, time=2023-03-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215407, encodeId=deee221540ea8, content=所以Awaiting VEIC Assignment中的VEIC到底是个什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fbd9383449, createdName=ms9000002097584198, createdTime=Wed Jul 17 14:12:46 CST 2024, time=2024-07-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211596, encodeId=7eb9221159672, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：还是听艰难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0e5680489, createdName=ms2000001467090742, createdTime=Tue Jun 25 16:28:02 CST 2024, time=2024-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204838, encodeId=63ab2204838c3, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：很慢啊，投稿到等审稿人认领一个月，然后等打分又一个月，速度真的是可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc119232111, createdName=ms3000002125368567, createdTime=Wed May 15 15:43:04 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2171584, encodeId=09f421e1584f0, content=请问这个杂志Instructions for authors的要求和给到的template模板要求不一致，应该按照哪一个来呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4f28656115, createdName=ms2000000932153408, createdTime=Tue Nov 28 23:04:31 CST 2023, time=2023-11-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1218505, encodeId=b8a012185056e, content=请问Output Styles下载的该杂志的参考文献格式和杂志要求的不一样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84202197639, createdName=120a90fem13(暂无昵称), createdTime=Tue May 10 17:30:26 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150883, encodeId=3e82215088322, content=这个杂志如何提交原始数据？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57035473318, createdName=淡忘Lrc, createdTime=Wed Aug 02 08:46:58 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1214240, encodeId=f5b3121424009, content=偏重的研究方向：细胞生物学 经验分享：一直显示awaiting ED assignment多久会有<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>下一步啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=21, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37c95472737, createdName=ms1000001579516810, createdTime=Mon Apr 25 22:15:47 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051482, encodeId=ec28105148229, content=请问各位有遇到过投稿一个多月了，一直是waiting reviewer assignment的状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/DF260C6FE6A83E05AA005306C7FA653C/100, createdBy=2c722184101, createdName=CasRx, createdTime=Wed Sep 15 14:06:19 CST 2021, time=2021-09-15, status=1, ipAttribution=)]

2023-03-21 Judy Bright 来自安徽省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：肺癌;小分子抑制剂
经验分享：2023.03.16 投稿后状态变化记录：
2023.03.17: Awaiting ED Assignment；
2023.03.21 : Awaiting VEIC Assignment;
目前是这样，，，

189 34

展开34条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216718, encodeId=37a82216e18e9, content=7.11投稿 awaiting ED 7.12 awaiting VEIC 7.24 awaiting Adm 是不是要拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068534123, createdName=pello11, createdTime=Wed Jul 24 23:03:56 CST 2024, time=2024-07-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2120848, encodeId=a0b9212084884, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肺癌;小分子抑制剂 经验分享：2023.03.16 投稿后状态变化记录： 2023.03.17: Awaiting ED Assignment； 2023.03.21 : Awaiting VEIC Assignment; 目前是这样，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Tue Mar 21 19:05:18 CST 2023, time=2023-03-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215407, encodeId=deee221540ea8, content=所以Awaiting VEIC Assignment中的VEIC到底是个什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fbd9383449, createdName=ms9000002097584198, createdTime=Wed Jul 17 14:12:46 CST 2024, time=2024-07-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211596, encodeId=7eb9221159672, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：还是听艰难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0e5680489, createdName=ms2000001467090742, createdTime=Tue Jun 25 16:28:02 CST 2024, time=2024-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204838, encodeId=63ab2204838c3, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：很慢啊，投稿到等审稿人认领一个月，然后等打分又一个月，速度真的是可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc119232111, createdName=ms3000002125368567, createdTime=Wed May 15 15:43:04 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2171584, encodeId=09f421e1584f0, content=请问这个杂志Instructions for authors的要求和给到的template模板要求不一致，应该按照哪一个来呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4f28656115, createdName=ms2000000932153408, createdTime=Tue Nov 28 23:04:31 CST 2023, time=2023-11-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1218505, encodeId=b8a012185056e, content=请问Output Styles下载的该杂志的参考文献格式和杂志要求的不一样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84202197639, createdName=120a90fem13(暂无昵称), createdTime=Tue May 10 17:30:26 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150883, encodeId=3e82215088322, content=这个杂志如何提交原始数据？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57035473318, createdName=淡忘Lrc, createdTime=Wed Aug 02 08:46:58 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1214240, encodeId=f5b3121424009, content=偏重的研究方向：细胞生物学 经验分享：一直显示awaiting ED assignment多久会有<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>下一步啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=21, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37c95472737, createdName=ms1000001579516810, createdTime=Mon Apr 25 22:15:47 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051482, encodeId=ec28105148229, content=请问各位有遇到过投稿一个多月了，一直是waiting reviewer assignment的状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/DF260C6FE6A83E05AA005306C7FA653C/100, createdBy=2c722184101, createdName=CasRx, createdTime=Wed Sep 15 14:06:19 CST 2021, time=2021-09-15, status=1, ipAttribution=)]

2024-07-17 ms9000002097584198 来自河北省

所以Awaiting VEIC Assignment中的VEIC到底是个什么意思

63 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216718, encodeId=37a82216e18e9, content=7.11投稿 awaiting ED 7.12 awaiting VEIC 7.24 awaiting Adm 是不是要拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068534123, createdName=pello11, createdTime=Wed Jul 24 23:03:56 CST 2024, time=2024-07-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2120848, encodeId=a0b9212084884, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肺癌;小分子抑制剂 经验分享：2023.03.16 投稿后状态变化记录： 2023.03.17: Awaiting ED Assignment； 2023.03.21 : Awaiting VEIC Assignment; 目前是这样，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Tue Mar 21 19:05:18 CST 2023, time=2023-03-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215407, encodeId=deee221540ea8, content=所以Awaiting VEIC Assignment中的VEIC到底是个什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fbd9383449, createdName=ms9000002097584198, createdTime=Wed Jul 17 14:12:46 CST 2024, time=2024-07-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211596, encodeId=7eb9221159672, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：还是听艰难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0e5680489, createdName=ms2000001467090742, createdTime=Tue Jun 25 16:28:02 CST 2024, time=2024-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204838, encodeId=63ab2204838c3, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：很慢啊，投稿到等审稿人认领一个月，然后等打分又一个月，速度真的是可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc119232111, createdName=ms3000002125368567, createdTime=Wed May 15 15:43:04 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2171584, encodeId=09f421e1584f0, content=请问这个杂志Instructions for authors的要求和给到的template模板要求不一致，应该按照哪一个来呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4f28656115, createdName=ms2000000932153408, createdTime=Tue Nov 28 23:04:31 CST 2023, time=2023-11-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1218505, encodeId=b8a012185056e, content=请问Output Styles下载的该杂志的参考文献格式和杂志要求的不一样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84202197639, createdName=120a90fem13(暂无昵称), createdTime=Tue May 10 17:30:26 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150883, encodeId=3e82215088322, content=这个杂志如何提交原始数据？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57035473318, createdName=淡忘Lrc, createdTime=Wed Aug 02 08:46:58 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1214240, encodeId=f5b3121424009, content=偏重的研究方向：细胞生物学 经验分享：一直显示awaiting ED assignment多久会有<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>下一步啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=21, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37c95472737, createdName=ms1000001579516810, createdTime=Mon Apr 25 22:15:47 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051482, encodeId=ec28105148229, content=请问各位有遇到过投稿一个多月了，一直是waiting reviewer assignment的状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/DF260C6FE6A83E05AA005306C7FA653C/100, createdBy=2c722184101, createdName=CasRx, createdTime=Wed Sep 15 14:06:19 CST 2021, time=2021-09-15, status=1, ipAttribution=)]

2024-06-25 ms2000001467090742 来自北京

审稿速度:6.0 | 投稿命中率:25.0
经验分享：还是听艰难的

66 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216718, encodeId=37a82216e18e9, content=7.11投稿 awaiting ED 7.12 awaiting VEIC 7.24 awaiting Adm 是不是要拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068534123, createdName=pello11, createdTime=Wed Jul 24 23:03:56 CST 2024, time=2024-07-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2120848, encodeId=a0b9212084884, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肺癌;小分子抑制剂 经验分享：2023.03.16 投稿后状态变化记录： 2023.03.17: Awaiting ED Assignment； 2023.03.21 : Awaiting VEIC Assignment; 目前是这样，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Tue Mar 21 19:05:18 CST 2023, time=2023-03-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215407, encodeId=deee221540ea8, content=所以Awaiting VEIC Assignment中的VEIC到底是个什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fbd9383449, createdName=ms9000002097584198, createdTime=Wed Jul 17 14:12:46 CST 2024, time=2024-07-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211596, encodeId=7eb9221159672, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：还是听艰难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0e5680489, createdName=ms2000001467090742, createdTime=Tue Jun 25 16:28:02 CST 2024, time=2024-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204838, encodeId=63ab2204838c3, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：很慢啊，投稿到等审稿人认领一个月，然后等打分又一个月，速度真的是可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc119232111, createdName=ms3000002125368567, createdTime=Wed May 15 15:43:04 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2171584, encodeId=09f421e1584f0, content=请问这个杂志Instructions for authors的要求和给到的template模板要求不一致，应该按照哪一个来呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4f28656115, createdName=ms2000000932153408, createdTime=Tue Nov 28 23:04:31 CST 2023, time=2023-11-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1218505, encodeId=b8a012185056e, content=请问Output Styles下载的该杂志的参考文献格式和杂志要求的不一样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84202197639, createdName=120a90fem13(暂无昵称), createdTime=Tue May 10 17:30:26 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150883, encodeId=3e82215088322, content=这个杂志如何提交原始数据？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57035473318, createdName=淡忘Lrc, createdTime=Wed Aug 02 08:46:58 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1214240, encodeId=f5b3121424009, content=偏重的研究方向：细胞生物学 经验分享：一直显示awaiting ED assignment多久会有<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>下一步啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=21, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37c95472737, createdName=ms1000001579516810, createdTime=Mon Apr 25 22:15:47 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051482, encodeId=ec28105148229, content=请问各位有遇到过投稿一个多月了，一直是waiting reviewer assignment的状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/DF260C6FE6A83E05AA005306C7FA653C/100, createdBy=2c722184101, createdName=CasRx, createdTime=Wed Sep 15 14:06:19 CST 2021, time=2021-09-15, status=1, ipAttribution=)]

2024-05-15 ms3000002125368567 来自北京

审稿速度:3.0 | 投稿命中率:50.0
经验分享：很慢啊，投稿到等审稿人认领一个月，然后等打分又一个月，速度真的是可以

73 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216718, encodeId=37a82216e18e9, content=7.11投稿 awaiting ED 7.12 awaiting VEIC 7.24 awaiting Adm 是不是要拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068534123, createdName=pello11, createdTime=Wed Jul 24 23:03:56 CST 2024, time=2024-07-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2120848, encodeId=a0b9212084884, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肺癌;小分子抑制剂 经验分享：2023.03.16 投稿后状态变化记录： 2023.03.17: Awaiting ED Assignment； 2023.03.21 : Awaiting VEIC Assignment; 目前是这样，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Tue Mar 21 19:05:18 CST 2023, time=2023-03-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215407, encodeId=deee221540ea8, content=所以Awaiting VEIC Assignment中的VEIC到底是个什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fbd9383449, createdName=ms9000002097584198, createdTime=Wed Jul 17 14:12:46 CST 2024, time=2024-07-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211596, encodeId=7eb9221159672, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：还是听艰难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0e5680489, createdName=ms2000001467090742, createdTime=Tue Jun 25 16:28:02 CST 2024, time=2024-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204838, encodeId=63ab2204838c3, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：很慢啊，投稿到等审稿人认领一个月，然后等打分又一个月，速度真的是可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc119232111, createdName=ms3000002125368567, createdTime=Wed May 15 15:43:04 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2171584, encodeId=09f421e1584f0, content=请问这个杂志Instructions for authors的要求和给到的template模板要求不一致，应该按照哪一个来呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4f28656115, createdName=ms2000000932153408, createdTime=Tue Nov 28 23:04:31 CST 2023, time=2023-11-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1218505, encodeId=b8a012185056e, content=请问Output Styles下载的该杂志的参考文献格式和杂志要求的不一样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84202197639, createdName=120a90fem13(暂无昵称), createdTime=Tue May 10 17:30:26 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150883, encodeId=3e82215088322, content=这个杂志如何提交原始数据？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57035473318, createdName=淡忘Lrc, createdTime=Wed Aug 02 08:46:58 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1214240, encodeId=f5b3121424009, content=偏重的研究方向：细胞生物学 经验分享：一直显示awaiting ED assignment多久会有<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>下一步啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=21, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37c95472737, createdName=ms1000001579516810, createdTime=Mon Apr 25 22:15:47 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051482, encodeId=ec28105148229, content=请问各位有遇到过投稿一个多月了，一直是waiting reviewer assignment的状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/DF260C6FE6A83E05AA005306C7FA653C/100, createdBy=2c722184101, createdName=CasRx, createdTime=Wed Sep 15 14:06:19 CST 2021, time=2021-09-15, status=1, ipAttribution=)]

2023-11-28 ms2000000932153408 来自北京

请问这个杂志Instructions for authors的要求和给到的template模板要求不一致，应该按照哪一个来呢

124 0

[GetPortalCommentsPageByObjectIdResponse(id=2216718, encodeId=37a82216e18e9, content=7.11投稿 awaiting ED 7.12 awaiting VEIC 7.24 awaiting Adm 是不是要拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068534123, createdName=pello11, createdTime=Wed Jul 24 23:03:56 CST 2024, time=2024-07-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2120848, encodeId=a0b9212084884, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肺癌;小分子抑制剂 经验分享：2023.03.16 投稿后状态变化记录： 2023.03.17: Awaiting ED Assignment； 2023.03.21 : Awaiting VEIC Assignment; 目前是这样，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Tue Mar 21 19:05:18 CST 2023, time=2023-03-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215407, encodeId=deee221540ea8, content=所以Awaiting VEIC Assignment中的VEIC到底是个什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fbd9383449, createdName=ms9000002097584198, createdTime=Wed Jul 17 14:12:46 CST 2024, time=2024-07-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211596, encodeId=7eb9221159672, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：还是听艰难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0e5680489, createdName=ms2000001467090742, createdTime=Tue Jun 25 16:28:02 CST 2024, time=2024-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204838, encodeId=63ab2204838c3, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：很慢啊，投稿到等审稿人认领一个月，然后等打分又一个月，速度真的是可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc119232111, createdName=ms3000002125368567, createdTime=Wed May 15 15:43:04 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2171584, encodeId=09f421e1584f0, content=请问这个杂志Instructions for authors的要求和给到的template模板要求不一致，应该按照哪一个来呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4f28656115, createdName=ms2000000932153408, createdTime=Tue Nov 28 23:04:31 CST 2023, time=2023-11-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1218505, encodeId=b8a012185056e, content=请问Output Styles下载的该杂志的参考文献格式和杂志要求的不一样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84202197639, createdName=120a90fem13(暂无昵称), createdTime=Tue May 10 17:30:26 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150883, encodeId=3e82215088322, content=这个杂志如何提交原始数据？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57035473318, createdName=淡忘Lrc, createdTime=Wed Aug 02 08:46:58 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1214240, encodeId=f5b3121424009, content=偏重的研究方向：细胞生物学 经验分享：一直显示awaiting ED assignment多久会有<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>下一步啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=21, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37c95472737, createdName=ms1000001579516810, createdTime=Mon Apr 25 22:15:47 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051482, encodeId=ec28105148229, content=请问各位有遇到过投稿一个多月了，一直是waiting reviewer assignment的状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/DF260C6FE6A83E05AA005306C7FA653C/100, createdBy=2c722184101, createdName=CasRx, createdTime=Wed Sep 15 14:06:19 CST 2021, time=2021-09-15, status=1, ipAttribution=)]

2022-05-10 120a90fem13(暂无昵称)

请问Output Styles下载的该杂志的参考文献格式和杂志要求的不一样啊

262 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216718, encodeId=37a82216e18e9, content=7.11投稿 awaiting ED 7.12 awaiting VEIC 7.24 awaiting Adm 是不是要拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068534123, createdName=pello11, createdTime=Wed Jul 24 23:03:56 CST 2024, time=2024-07-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2120848, encodeId=a0b9212084884, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肺癌;小分子抑制剂 经验分享：2023.03.16 投稿后状态变化记录： 2023.03.17: Awaiting ED Assignment； 2023.03.21 : Awaiting VEIC Assignment; 目前是这样，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Tue Mar 21 19:05:18 CST 2023, time=2023-03-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215407, encodeId=deee221540ea8, content=所以Awaiting VEIC Assignment中的VEIC到底是个什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fbd9383449, createdName=ms9000002097584198, createdTime=Wed Jul 17 14:12:46 CST 2024, time=2024-07-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211596, encodeId=7eb9221159672, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：还是听艰难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0e5680489, createdName=ms2000001467090742, createdTime=Tue Jun 25 16:28:02 CST 2024, time=2024-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204838, encodeId=63ab2204838c3, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：很慢啊，投稿到等审稿人认领一个月，然后等打分又一个月，速度真的是可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc119232111, createdName=ms3000002125368567, createdTime=Wed May 15 15:43:04 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2171584, encodeId=09f421e1584f0, content=请问这个杂志Instructions for authors的要求和给到的template模板要求不一致，应该按照哪一个来呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4f28656115, createdName=ms2000000932153408, createdTime=Tue Nov 28 23:04:31 CST 2023, time=2023-11-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1218505, encodeId=b8a012185056e, content=请问Output Styles下载的该杂志的参考文献格式和杂志要求的不一样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84202197639, createdName=120a90fem13(暂无昵称), createdTime=Tue May 10 17:30:26 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150883, encodeId=3e82215088322, content=这个杂志如何提交原始数据？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57035473318, createdName=淡忘Lrc, createdTime=Wed Aug 02 08:46:58 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1214240, encodeId=f5b3121424009, content=偏重的研究方向：细胞生物学 经验分享：一直显示awaiting ED assignment多久会有<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>下一步啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=21, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37c95472737, createdName=ms1000001579516810, createdTime=Mon Apr 25 22:15:47 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051482, encodeId=ec28105148229, content=请问各位有遇到过投稿一个多月了，一直是waiting reviewer assignment的状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/DF260C6FE6A83E05AA005306C7FA653C/100, createdBy=2c722184101, createdName=CasRx, createdTime=Wed Sep 15 14:06:19 CST 2021, time=2021-09-15, status=1, ipAttribution=)]

2023-08-02 淡忘Lrc 来自陕西省

这个杂志如何提交原始数据？

90 0

[GetPortalCommentsPageByObjectIdResponse(id=2216718, encodeId=37a82216e18e9, content=7.11投稿 awaiting ED 7.12 awaiting VEIC 7.24 awaiting Adm 是不是要拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068534123, createdName=pello11, createdTime=Wed Jul 24 23:03:56 CST 2024, time=2024-07-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2120848, encodeId=a0b9212084884, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肺癌;小分子抑制剂 经验分享：2023.03.16 投稿后状态变化记录： 2023.03.17: Awaiting ED Assignment； 2023.03.21 : Awaiting VEIC Assignment; 目前是这样，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Tue Mar 21 19:05:18 CST 2023, time=2023-03-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215407, encodeId=deee221540ea8, content=所以Awaiting VEIC Assignment中的VEIC到底是个什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fbd9383449, createdName=ms9000002097584198, createdTime=Wed Jul 17 14:12:46 CST 2024, time=2024-07-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211596, encodeId=7eb9221159672, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：还是听艰难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0e5680489, createdName=ms2000001467090742, createdTime=Tue Jun 25 16:28:02 CST 2024, time=2024-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204838, encodeId=63ab2204838c3, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：很慢啊，投稿到等审稿人认领一个月，然后等打分又一个月，速度真的是可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc119232111, createdName=ms3000002125368567, createdTime=Wed May 15 15:43:04 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2171584, encodeId=09f421e1584f0, content=请问这个杂志Instructions for authors的要求和给到的template模板要求不一致，应该按照哪一个来呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4f28656115, createdName=ms2000000932153408, createdTime=Tue Nov 28 23:04:31 CST 2023, time=2023-11-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1218505, encodeId=b8a012185056e, content=请问Output Styles下载的该杂志的参考文献格式和杂志要求的不一样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84202197639, createdName=120a90fem13(暂无昵称), createdTime=Tue May 10 17:30:26 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150883, encodeId=3e82215088322, content=这个杂志如何提交原始数据？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57035473318, createdName=淡忘Lrc, createdTime=Wed Aug 02 08:46:58 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1214240, encodeId=f5b3121424009, content=偏重的研究方向：细胞生物学 经验分享：一直显示awaiting ED assignment多久会有<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>下一步啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=21, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37c95472737, createdName=ms1000001579516810, createdTime=Mon Apr 25 22:15:47 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051482, encodeId=ec28105148229, content=请问各位有遇到过投稿一个多月了，一直是waiting reviewer assignment的状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/DF260C6FE6A83E05AA005306C7FA653C/100, createdBy=2c722184101, createdName=CasRx, createdTime=Wed Sep 15 14:06:19 CST 2021, time=2021-09-15, status=1, ipAttribution=)]

2022-04-25 ms1000001579516810

偏重的研究方向：细胞生物学
经验分享：一直显示awaiting ED assignment多久会有#期刊论坛#下一步啊？

409 21

展开21条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216718, encodeId=37a82216e18e9, content=7.11投稿 awaiting ED 7.12 awaiting VEIC 7.24 awaiting Adm 是不是要拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068534123, createdName=pello11, createdTime=Wed Jul 24 23:03:56 CST 2024, time=2024-07-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2120848, encodeId=a0b9212084884, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肺癌;小分子抑制剂 经验分享：2023.03.16 投稿后状态变化记录： 2023.03.17: Awaiting ED Assignment； 2023.03.21 : Awaiting VEIC Assignment; 目前是这样，，，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=34, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220323/c7cf4e6998eb4c7b9c22a01d070c1561/eac82b677dd4471abc7021cc1ba93665.jpg, createdBy=a70d6506235, createdName=Judy Bright, createdTime=Tue Mar 21 19:05:18 CST 2023, time=2023-03-21, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2215407, encodeId=deee221540ea8, content=所以Awaiting VEIC Assignment中的VEIC到底是个什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fbd9383449, createdName=ms9000002097584198, createdTime=Wed Jul 17 14:12:46 CST 2024, time=2024-07-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2211596, encodeId=7eb9221159672, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：还是听艰难的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df0e5680489, createdName=ms2000001467090742, createdTime=Tue Jun 25 16:28:02 CST 2024, time=2024-06-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204838, encodeId=63ab2204838c3, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：很慢啊，投稿到等审稿人认领一个月，然后等打分又一个月，速度真的是可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc119232111, createdName=ms3000002125368567, createdTime=Wed May 15 15:43:04 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2171584, encodeId=09f421e1584f0, content=请问这个杂志Instructions for authors的要求和给到的template模板要求不一致，应该按照哪一个来呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4f28656115, createdName=ms2000000932153408, createdTime=Tue Nov 28 23:04:31 CST 2023, time=2023-11-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1218505, encodeId=b8a012185056e, content=请问Output Styles下载的该杂志的参考文献格式和杂志要求的不一样啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=84202197639, createdName=120a90fem13(暂无昵称), createdTime=Tue May 10 17:30:26 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150883, encodeId=3e82215088322, content=这个杂志如何提交原始数据？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57035473318, createdName=淡忘Lrc, createdTime=Wed Aug 02 08:46:58 CST 2023, time=2023-08-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1214240, encodeId=f5b3121424009, content=偏重的研究方向：细胞生物学 经验分享：一直显示awaiting ED assignment多久会有<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>下一步啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=409, replyNumber=21, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37c95472737, createdName=ms1000001579516810, createdTime=Mon Apr 25 22:15:47 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051482, encodeId=ec28105148229, content=请问各位有遇到过投稿一个多月了，一直是waiting reviewer assignment的状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/DF260C6FE6A83E05AA005306C7FA653C/100, createdBy=2c722184101, createdName=CasRx, createdTime=Wed Sep 15 14:06:19 CST 2021, time=2021-09-15, status=1, ipAttribution=)]

2021-09-15 CasRx

请问各位有遇到过投稿一个多月了，一直是waiting reviewer assignment的状态吗？

357 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务